• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种利用[F-18]氟米索硝唑PET时间-活性数据定量肿瘤缺氧的建模方法。

A modeling approach for quantifying tumor hypoxia with [F-18]fluoromisonidazole PET time-activity data.

作者信息

Casciari J J, Graham M M, Rasey J S

机构信息

Department of Radiation Oncology, University of Washington Medical Center, Seattle 91895, USA.

出版信息

Med Phys. 1995 Jul;22(7):1127-39. doi: 10.1118/1.597506.

DOI:10.1118/1.597506
PMID:7565388
Abstract

[F-18]fluoromisonidazole (FMISO), a positron-emitting nitroimidazole, binds preferentially to hypoxic cells. It has been used to image hypoxia in human tumors with positron emission tomography (PET). In order to quantify tumor oxygenation status from these PET data, a kinetic model of FMISO cellular bioreduction has been developed to relate cellular oxygen concentration to the cellular FMISO reaction rate constant, kappa A. Also, a compartmental model of FMISO transport and metabolism has been developed to compute the volume average kappa A in tissue regions from [F-18]FMISO PET time-activity data. This compartmental model was characterized using Monte Carlo simulations and [F-18]FMISO PET time-activity data. The model performed well in Monte Carlo simulations; performance was enhanced by fixing three of the seven model parameters at physiologically reasonable values. The four parameters optimized were blood flow rate, kappa A for two partial volume/spillover correction factors. The model was able to accurately determine kappa A for a variety of computer-generated time-activity curv including those for hypothetical heterogeneous tissue regions and poorly perfused tissue regions. The model was also able to fit [H-3]FMISO time-activity data from 36B-10 rat tumors as well as [F-18]FMISO PET time-activity data from a human patient with a base of the tongue squamous cell carcinoma. The kappa A values in muscles ROIs were comparable to those in well-oxygenated cell monolayers while kappa A values in tumor ROIs were greater, suggesting the presence of hypoxic cells in the tumor.

摘要

[F-18]氟米索硝唑(FMISO)是一种正电子发射型硝基咪唑,优先与缺氧细胞结合。它已被用于通过正电子发射断层扫描(PET)对人类肿瘤中的缺氧情况进行成像。为了从这些PET数据中量化肿瘤氧合状态,已开发出FMISO细胞生物还原动力学模型,以将细胞氧浓度与细胞FMISO反应速率常数κA相关联。此外,还开发了FMISO转运和代谢的房室模型,以根据[F-18]FMISO PET时间-活度数据计算组织区域中的体积平均κA。该房室模型通过蒙特卡罗模拟和[F-18]FMISO PET时间-活度数据进行了表征。该模型在蒙特卡罗模拟中表现良好;通过将七个模型参数中的三个固定在生理合理值,性能得到了提高。优化的四个参数是血流速率、两个部分体积/溢出校正因子的κA。该模型能够准确确定各种计算机生成的时间-活度曲线的κA,包括那些假设的异质组织区域和灌注不良组织区域的曲线。该模型还能够拟合来自36B-10大鼠肿瘤的[H-3]FMISO时间-活度数据以及来自一名舌底鳞状细胞癌患者的[F-18]FMISO PET时间-活度数据。肌肉感兴趣区域(ROI)中的κA值与氧合良好的细胞单层中的κA值相当,而肿瘤ROI中的κA值更大,表明肿瘤中存在缺氧细胞。

相似文献

1
A modeling approach for quantifying tumor hypoxia with [F-18]fluoromisonidazole PET time-activity data.一种利用[F-18]氟米索硝唑PET时间-活性数据定量肿瘤缺氧的建模方法。
Med Phys. 1995 Jul;22(7):1127-39. doi: 10.1118/1.597506.
2
Identifying hypoxia in human tumors: A correlation study between 18F-FMISO PET and the Eppendorf oxygen-sensitive electrode.鉴定人体肿瘤缺氧:18F-FMISO PET 与 Eppendorf 氧敏感电极的相关性研究。
Acta Oncol. 2010 Oct;49(7):934-40. doi: 10.3109/0284186X.2010.516274.
3
F-Fluoromisonidazole Kinetic Modeling for Characterization of Tumor Perfusion and Hypoxia in Response to Antiangiogenic Therapy.用于表征抗血管生成治疗反应中肿瘤灌注和缺氧的F-氟米索硝唑动力学建模
J Nucl Med. 2017 Oct;58(10):1567-1573. doi: 10.2967/jnumed.117.190892. Epub 2017 Mar 30.
4
Tumor hypoxia imaging in orthotopic liver tumors and peritoneal metastasis: a comparative study featuring dynamic 18F-MISO and 124I-IAZG PET in the same study cohort.原位肝肿瘤及腹膜转移瘤的肿瘤缺氧成像:一项在同一研究队列中采用动态18F-MISO和124I-IAZG PET的对比研究。
Eur J Nucl Med Mol Imaging. 2008 Jan;35(1):39-46. doi: 10.1007/s00259-007-0522-2. Epub 2007 Sep 5.
5
Modelling and simulation of the influence of acute and chronic hypoxia on [18F]fluoromisonidazole PET imaging.急性和慢性缺氧对 [18F]氟莫司汀 PET 成像影响的建模与模拟。
Phys Med Biol. 2012 Mar 21;57(6):1675-84. doi: 10.1088/0031-9155/57/6/1675. Epub 2012 Mar 7.
6
Pharmacokinetic Analysis of Dynamic F-Fluoromisonidazole PET Data in Non-Small Cell Lung Cancer.非小细胞肺癌中动态F-氟米索硝唑PET数据的药代动力学分析
J Nucl Med. 2017 Jun;58(6):911-919. doi: 10.2967/jnumed.116.180422. Epub 2017 Feb 23.
7
18F-Fluoromisonidazole Quantification of Hypoxia in Human Cancer Patients Using Image-Derived Blood Surrogate Tissue Reference Regions.使用图像衍生的血液替代组织参考区域对人类癌症患者的缺氧情况进行18F-氟米索硝唑定量分析。
J Nucl Med. 2015 Aug;56(8):1223-8. doi: 10.2967/jnumed.115.158717. Epub 2015 Jun 25.
8
[18F]Fluoroazomycinarabinofuranoside (18FAZA) and [18F]Fluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors.[18F]氟阿糖胞苷(18FAZA)与[18F]氟米索硝唑(18FMISO):它们在缺氧细胞中的选择性摄取及在实验大鼠肿瘤中的正电子发射断层显像(PET)成像的比较研究
Nucl Med Biol. 2003 Apr;30(3):317-26. doi: 10.1016/s0969-8051(02)00442-0.
9
Modeling of FMISO [F] nanoparticle PET tracer in normal-cancerous tissue based on real clinical image.基于真实临床图像的 FMISO [F] 纳米颗粒 PET 示踪剂在正常-癌组织中的建模。
Microvasc Res. 2018 Jul;118:20-30. doi: 10.1016/j.mvr.2018.02.002. Epub 2018 Feb 3.
10
High reproducibility of tumor hypoxia evaluated by 18F-fluoromisonidazole PET for head and neck cancer.18F-氟咪索硝唑 PET 评估头颈部肿瘤缺氧的高重复性。
J Nucl Med. 2013 Feb;54(2):201-7. doi: 10.2967/jnumed.112.109330. Epub 2013 Jan 15.

引用本文的文献

1
Quantification of Hypoxia in Human Glioblastoma using PET with 18F-FMISO.使用18F-FMISO正电子发射断层扫描(PET)对人类胶质母细胞瘤中的缺氧情况进行定量分析。
Nucl Med Mol Imaging. 2021 Jun;55(3):107-115. doi: 10.1007/s13139-021-00693-8. Epub 2021 Mar 25.
2
Quantitative assessment of dynamic F-flumethycholine PET and dynamic contrast enhanced MRI in high risk prostate cancer.高危前列腺癌中动态F-氟甲基胆碱PET与动态对比增强MRI的定量评估
Br J Radiol. 2019 Feb;92(1094):20180568. doi: 10.1259/bjr.20180568. Epub 2018 Nov 14.
3
Longitudinal PET imaging of tumor hypoxia during the course of radiotherapy.
放疗过程中肿瘤乏氧的纵向 PET 成像。
Eur J Nucl Med Mol Imaging. 2018 Nov;45(12):2201-2217. doi: 10.1007/s00259-018-4116-y. Epub 2018 Aug 20.
4
Whole tumor kinetics analysis of F-fluoromisonidazole dynamic PET scans of non-small cell lung cancer patients, and correlations with perfusion CT blood flow.非小细胞肺癌患者F-氟米索硝唑动态PET扫描的全肿瘤动力学分析及其与灌注CT血流的相关性。
EJNMMI Res. 2018 Aug 1;8(1):73. doi: 10.1186/s13550-018-0430-4.
5
Overexpression of Receptor Tyrosine Kinase EphB4 Triggers Tumor Growth and Hypoxia in A375 Melanoma Xenografts: Insights from Multitracer Small Animal Imaging Experiments.EphB4 受体酪氨酸激酶过表达触发 A375 黑色素瘤异种移植瘤的肿瘤生长和缺氧:来自多示踪剂小动物成像实验的见解。
Molecules. 2018 Feb 17;23(2):444. doi: 10.3390/molecules23020444.
6
Impact of tissue transport on PET hypoxia quantification in pancreatic tumours.组织运输对胰腺肿瘤PET缺氧定量分析的影响。
EJNMMI Res. 2017 Dec 22;7(1):101. doi: 10.1186/s13550-017-0347-3.
7
Invited editorial for the paper by Silvoniemi et al. "Repeatability of tumor hypoxia imaging using [F]EF5 PET/CT in head and neck cancer." in this issue of EJNMMI.本期《欧洲核医学与分子影像杂志》(EJNMMI)中,Silvoniemi等人所著论文《头颈部癌中使用[F]EF5 PET/CT进行肿瘤缺氧成像的可重复性》的特邀社论。
Eur J Nucl Med Mol Imaging. 2018 Feb;45(2):159-160. doi: 10.1007/s00259-017-3889-8.
8
[F]Fluoromisonidazole PET in rectal cancer.[F]氟代米索硝唑正电子发射断层扫描在直肠癌中的应用
EJNMMI Res. 2017 Sep 20;7(1):78. doi: 10.1186/s13550-017-0324-x.
9
F-fluoromisonidazole uptake in advanced stage non-small cell lung cancer: A voxel-by-voxel PET kinetics study.晚期非小细胞肺癌氟-氟莫司汀摄取:体素 PET 动力学研究。
Med Phys. 2017 Sep;44(9):4665-4676. doi: 10.1002/mp.12416. Epub 2017 Jul 21.
10
Pharmacokinetic Analysis of Dynamic F-Fluoromisonidazole PET Data in Non-Small Cell Lung Cancer.非小细胞肺癌中动态F-氟米索硝唑PET数据的药代动力学分析
J Nucl Med. 2017 Jun;58(6):911-919. doi: 10.2967/jnumed.116.180422. Epub 2017 Feb 23.